OncoCyte Total Liabilities 2014-2023 | OCX
OncoCyte Annual Total Liabilities (Millions of US $) |
|
---|---|
2023 | $54 |
2022 | $66 |
2021 | $94 |
2020 | $22 |
2019 | $9 |
2018 | $6 |
2017 | $6 |
2016 | $5 |
2015 | $2 |
2014 | $6 |
2013 | $5 |
OncoCyte Quarterly Total Liabilities (Millions of US $) |
|
---|---|
2023-12-31 | $54 |
2023-09-30 | $44 |
2023-06-30 | $44 |
2023-03-31 | $45 |
2022-12-31 | $66 |
2022-09-30 | $80 |
2022-06-30 | $88 |
2022-03-31 | $89 |
2021-12-31 | $94 |
2021-09-30 | $69 |
2021-06-30 | $75 |
2021-03-31 | $23 |
2020-12-31 | $22 |
2020-09-30 | $23 |
2020-06-30 | $24 |
2020-03-31 | $23 |
2019-12-31 | $9 |
2019-09-30 | $3 |
2019-06-30 | $4 |
2019-03-31 | $3 |
2018-12-31 | $6 |
2018-09-30 | $5 |
2018-06-30 | $5 |
2018-03-31 | $7 |
2017-12-31 | $6 |
2017-09-30 | $6 |
2017-06-30 | $7 |
2017-03-31 | $6 |
2016-12-31 | $5 |
2016-09-30 | $4 |
2016-06-30 | $3 |
2016-03-31 | $3 |
2015-12-31 | $2 |
2015-09-30 | $0 |
2015-06-30 | $0 |
2015-03-31 | $0 |
2014-12-31 | $6 |
2013-12-31 | $5 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.021B | $0.002B |
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $121.982B | 15.31 |
Cencora (COR) | United States | $45.721B | 17.82 |
ICON (ICLR) | Ireland | $24.881B | 23.49 |
DiDi Global (DIDIY) | China | $23.865B | 0.00 |
Avantor (AVTR) | United States | $16.588B | 24.42 |
Viatris (VTRS) | United States | $13.847B | 3.98 |
CochLear (CHEOY) | Australia | $13.505B | 0.00 |
Revvity (RVTY) | United States | $12.674B | 22.21 |
Medpace Holdings (MEDP) | United States | $12.327B | 40.56 |
Charles River Laboratories (CRL) | United States | $11.986B | 21.85 |
Natera (NTRA) | United States | $11.509B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.385B | 0.00 |
Solventum (SOLV) | United States | $11.239B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
HealthEquity (HQY) | United States | $6.843B | 51.12 |
Organon (OGN) | United States | $4.843B | 4.66 |
Bausch + Lomb (BLCO) | Canada | $4.828B | 19.35 |
Doximity (DOCS) | United States | $4.479B | 33.35 |
PACS (PACS) | United States | $3.736B | 0.00 |
Sotera Health (SHC) | United States | $3.190B | 15.65 |
Surgery Partners (SGRY) | United States | $3.131B | 28.98 |
Progyny (PGNY) | United States | $3.103B | 52.08 |
GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
Life Times (LTH) | United States | $2.557B | 27.08 |
Premier (PINC) | United States | $2.523B | 9.24 |
AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
Agilon Health (AGL) | United States | $2.039B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.825B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.390B | 0.00 | |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
NovoCure (NVCR) | Jersey | $1.371B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.995B | 0.00 |
Pediatrix Medical (MD) | United States | $0.757B | 7.83 |
Embecta (EMBC) | United States | $0.583B | 3.85 |
GeneDx Holdings (WGS) | United States | $0.545B | 0.00 |
InnovAge Holding (INNV) | United States | $0.527B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.525B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.517B | 0.00 |
Enhabit (EHAB) | United States | $0.511B | 46.27 |
LifeMD (LFMD) | United States | $0.476B | 0.00 |
CareDx (CDNA) | United States | $0.475B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
MultiPlan (MPLN) | United States | $0.414B | 0.00 |
Beauty Health (SKIN) | United States | $0.391B | 0.00 |
DocGo (DCGO) | United States | $0.353B | 56.50 |
Sera Prognostics (SERA) | United States | $0.338B | 0.00 |
ModivCare (MODV) | United States | $0.317B | 4.20 |
Sharecare (SHCR) | United States | $0.263B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
Biodesix (BDSX) | United States | $0.143B | 0.00 |
So-Young (SY) | China | $0.127B | 42.67 |
Oncology Institute (TOI) | United States | $0.083B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
NeueHealth (NEUE) | United States | $0.051B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.035B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
Nutex Health (NUTX) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |